Cannabis Law Report

JUNE 21, 2021

Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Life Network

SEPTEMBER 16, 2022

BDSA’s latest report suggests that recreational cannabis access affects longer standing medical market. Access with a medical card encourages patients to buy heavily taxed adult-use cannabis. But is recreational access a benefit or hinderance on medical cannabis?

Access 109

Access Recreational Patients Cannabis 109

Cannabis Law Report

DECEMBER 18, 2020

15, 2020 /PRNewswire/ — CME Group, the world’s leading and most diverse derivatives marketplace, today announced that customers can now access hemp … Read More. The post CME Group Adds New Hemp Pricing Data to CME DataMine first appeared on Cannabis Law Report. CHICAGO , Dec.

Data 98

Data Hemp Access Law 98

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 168

Access Patients Chronic Pain Law 168

Cannabis Law Report

JULY 2, 2022

reported a data breach stemming from a misconfigured web application that caused personal information to be accessible on the company’s website. On June 17, 2022, Silverstreak filed an official notice of the breach and sent out data breach letters to all affected parties. Can a Company Be Liable for an Accidental Data Breach?

Data 52

Data Access Topical Cannabis 52

Cannabis Law Report

AUGUST 8, 2021

A new poll, commissioned by the Canadian Psychedelic Association, has highlighted widespread support for legal access to psilocybin-assisted therapy among Canadians. The Canadian Psychedelic Association (CPA) has today released data from a telephone survey of over 1,000 Canadian adults.

Therapy 105

Therapy Access Legalization Education 105

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Access Psychiatry deal headline, upfront, milestone and royalty data. Analysis of Psychiatry deal structure. Report Scope.

Access 52

Access Data Pharmaceutical Research and Development 52

Veriheal

DECEMBER 14, 2021

An Analysis of Nationwide EVALI Data. Acknowledging this data, the study’s authors called for states to consider initiating home cultivation policies. The post New Data Reveals Legal States Experienced Fewer Cases of EVALI appeared first on Cannabis Central.

Data 98

Data Vaping Legalization Consumption 98

NORML

APRIL 6, 2020

A team of researchers affiliated with the University of Miami School of Nursing are collecting epidemiological data to better evaluate how cannabis consumers, and patients in particular, are responding to the COVID-19 pandemic. “If COVID-19 has taught us anything, it is that population-based data is vital to make informed decisions. .

Data 277

Data Access Patients Collective 277

Cannabis Law Report

FEBRUARY 10, 2023

Canada’s Globe & Mail reports on their court case A years-long access-to-information battle between journalists and Health Canada over data on the locations of large-scale medical cannabis growers has concluded with a Federal Court judge ruling that even city or town information could risk identifying patients and is therefore protected from (..)

Data 52

Data Access Patients Cannabis 52

The Cannigma

JANUARY 16, 2021

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf. Edited and mixed by Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

MAY 12, 2022

The new tool lets individual users and businesses connect with the entire Canxchange universe through a public chat feature, and gives them instant access to the company’s sales and support team. Under a limited access “light” version users can network and access data. Two options. Major traders.

Access 52

Access Research and Development Hemp Data 52

NORML

DECEMBER 29, 2020

According to statewide polling data, 90 percent of Kentucky residents support regulating medical marijuana access. The post States to Watch in 2021: Kentucky appeared first on NORML.

Data 246

Data Access Marijuana Cannabis 246

Cannabis Law Report

DECEMBER 27, 2019

Companies today need a more viable business model , one that transcends geography, mobility challenges faced by certain demographics including seniors, improves patient engagement and creates real time data scalability. AI-Powered search platform maximizes access to publications. Mobile communities advance consumer research.

Clinical Trials 85

Clinical Trials Access Research and Development Supply Chain 85

NORML

FEBRUARY 26, 2019

They look at this constantly, they look at the data, they look at the science and they make those recommendations to us on that basis.” When asked about the likelihood of the league changing its policies on the use of medical marijuana, Goodell answered, “We rely on our medical advisors to give us advice.

Access 199

Access Medicine Policy Media 199

Cannabis Law Report

FEBRUARY 24, 2021

MSN data give it the “that’s clever” angle with their headline Analysis: Aussie cannabis firms go capital light as they… Read More. The post Australian Firms To Try & Access Euro Market On The Cheap first appeared on Cannabis Law Report.

Access 52

Access Data Law Cannabis 52

Cannabis Law Report

JANUARY 7, 2022

Our NXTecK™ platform is introducing scalable, aggregated, and normalized consumer data with an attribution model, so you know exactly where and how to focus your multi-channel strategies and achieve your digital marketing goals. Free Access to Equio ®.

Data 52

Data Research and Development Access Retail 52

Cannabis Law Report

NOVEMBER 9, 2019

New Frontier Data’s Consumer Insight Series: Cannabis Consumer Retail Engagement , explores consumer purchasing habits and what influences them. New Frontier Data has identified five forces changing the consumer landscape: Expanding legal access. 1-2019: Cannabis Consumer Retail Engagement. Therapeutic efficacy.

Data 45

Data Retail Dispensary Access 45

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

JANUARY 23, 2020

Click on image to access THSuite website. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry. THSuite Company Profile.

Data 59

Data Dispensary Patients Medicine 59

Cannabis Law Report

JANUARY 6, 2022

The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. From there, former researchers working for big pharma will dictate what products are available to patients, how treatments are accessed, and cost. Threat to Patient Access in Oregon. You can contact Brett Mulligan at ?

Access 52

Access Patients Research and Development Treatment 52

NORML

AUGUST 20, 2019

The self-reported use of marijuana by teenagers continues to decline nationally, according to federal data reported by the United States Substance Abuse and Mental Health Services Administration (SAMHSA). The agency’s 2018 report finds that past-year marijuana use by those ages 12 to 17 has fallen consistently since 2002, from 15.8

Marijuana 206

Marijuana Data Access Environment 206

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

SpeedWeed

JULY 18, 2021

The general population in states where cannabis is legal has very easy access to a wide array of high-potency cannabis products, including extremely high-potency cannabis concentrates which can exceed 90% THC, and we’ve been limited to studying the whole plant with under 10% THC.”. View original article.

Concentrates 98

Concentrates THC Data CBD 98

Cannabis Law Report

JANUARY 20, 2023

When Oregon voters passed Measure 109 in 2020, to create a legal framework for access to psilocybin services, the ballot initiative explicitly prevented the government from collecting that sensitive personal information without consent. […]

Data 52

Data Patients Legislation Collective 52

Cannabis Law Report

NOVEMBER 16, 2021

(“WM Technology” or the “Company”) (Nasdaq: MAPS), a leading technology and software infrastructure provider to the cannabis industry, has released its first data and insights report, titled ‘Cannabis in America’. According to Weedmaps’ orders data, orders in H1 2021 increased by 55%, compared to H1 2020. Methodology.

Data 52

Data Business Retail Dispensary 52

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings.

CBD 284

CBD Clinical Trials Data Treatment 284

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.

Chronic Pain 329

Chronic Pain Clinical Trials Data Patients 329

Cannabis Law Report

AUGUST 23, 2022

Spotlight PA sought that data to better understand the impact of the agency’s unusual and controversial decision to endorse cannabis as a treatment option for opioid use disorder. The newsroom specifically requested aggregate data — information that would not identify individual patients.

Data 52

Data Treatment Patients Chronic Pain 52

Cannabis Law Report

MAY 14, 2022

One of the largest and arguably sustainable customer bases, however, is consumers with some sort of health or therapeutic need for which they are unable to access medicinal cannabis. One potential consequence of the FSA’s drive to rein in the UK’s CBD industry is reduced access to the previously available wide range of products.

Access 52

Access CBD Research and Development Medicine 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Peer-reviewed analysis.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

JUNE 23, 2021

According to a recent analysis conducted by cannabis marketing company Digital Third Coast , consumers want even more access, more convenience, and also more restrictions, at least when it comes to advertising cannabis. Digital Third Coast analyzed Google (NASDAQ: GOOG)searches in all fifty states and 34 of the largest U.S.

Data 66

Data Decriminalization Legalization Cannabis 66

SpeedWeed

JUNE 2, 2021

Data from Marijuana Business Daily’s 2021 Annual Marijuana Business Factbook puts the growth potential of the cannabis industry over the next several years into perspective. According to the data in the 2021 Annual Marijuana Business Factbook , U.S. Cannabis Sales Growth. cannabis sales will climb to $48.4 View original article.

Data 40

Data Media Business Cannabis 40

NORML

APRIL 7, 2020

Incidences of the vaping-related lung illness EVALI (e-cigarette or vaping product use-associated lung injury) are primarily concentrated to jurisdictions where adult-use cannabis consumption is prohibited, according to data published in the Journal of the American Medical Association (JAMA) Network Open.

Vaping 277

Vaping Legalization Concentrates Access 277

NORML

JUNE 10, 2019

Military veterans who participate in a state’s medical marijuana access program frequently report substituting cannabis for alcohol and other controlled substances, according to data published in The American Journal of Drug and Alcohol Abuse. ”

Chronic Pain 260

Chronic Pain Access Collective Medicine 260

NORML

FEBRUARY 28, 2020

Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. Although the state’s medical cannabis access program has been operational for some two decades, Maine officials only began tracking caregiver-related tax revenue in February of 2019.

Data 191

Data Patients Retail Programs 191